CCR5-Delta32: implications in SLE development

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease influenced by genetic and environmental factors.
• Elevated chemokine levels are observed in active SLE.
• C-C chemokine receptor type 5 (CCR5) plays a role in inflammatory cell recruitment.

Purpose of the Study:

• To investigate the association between the CCR5∆32 polymorphism and SLE in a Portuguese cohort.
• To determine if CCR5∆32 allele frequency differs between SLE patients and healthy controls.

Main Methods:

• Case-control study design.
• Genotyping of the CCR5∆32 polymorphism in 219 SLE patients and 205 healthy controls.
• Statistical analysis to compare allele frequencies and assess association (Odds Ratio, P-value).

Main Results:

• The frequency of CCR5/∆32 heterozygotes was significantly lower in SLE patients (8%) compared to controls (15%).
• An odds ratio of 0.5162 (P = 0.0319) indicated a protective association.
• This suggests the CCR5∆32 allele may confer resistance to SLE development.

Conclusions:

• The CCR5∆32 allele demonstrates a protective association with systemic lupus erythematosus.
• These findings underscore the potential role of CCR5-expressing Th1 cells in SLE pathogenesis.
• Further research into CCR5 modulation could offer therapeutic insights for SLE.